ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07735
0,00%
Bitcoin
62.967,96
0,13%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Akoya BioSciences Inc (AKYA)

  7. Akoya BioSciences Inc (AKYA) News

AKYA Akoya BioSciences Inc

4,04
0,05 (1,25%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Akoya BioSciences Inc AKYA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,05 1,25% 4,04 22:56:32
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,02 3,92 4,2288 4,04 3,99
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202414:00GLOBEAkoya Biosciences and Shanghai KR Pharmtech Announce Chinese..
22.4.202422:05GLOBEAkoya to Report First Quarter 2024 Financial Results on May..
05.4.202414:00GLOBEAkoya Biosciences Showcases Spatial Biology 2.0 Solutions at..
04.3.202423:18EDGAR2Form 8-K - Current report
04.3.202422:05GLOBEAkoya Reports Record Revenue in the Fourth Quarter of 2023..
04.3.202412:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
02.3.202403:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.3.202403:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.3.202403:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.3.202403:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202415:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202422:05GLOBEAkoya to Report Fourth Quarter and Full Year 2023 Financial..
18.1.202414:00GLOBEAkoya Biosciences’ Technology Enables Queensland Spatial..
10.1.202422:02EDGAR2Form 8-K - Current report
10.1.202414:00GLOBEAkoya Biosciences Announces that Garry Nolan, Ph.D., James..
08.1.202421:57DJNAkoya Biosciences Shares Jump on 2024 Outlook, Thermo Fisher..
08.1.202412:02EDGAR2Form 8-K - Current report
07.1.202414:00GLOBEAkoya Biosciences Deploys the MaxFuse Algorithm Co-Developed..
03.1.202414:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21.12.202301:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202314:05GLOBEAkoya to Participate at 42nd Annual J.P. Morgan Healthcare..
19.12.202322:23EDGAR2Form 144 - Report of proposed sale of securities
14.12.202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202300:33EDGAR2Form 144 - Report of proposed sale of securities
27.11.202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202322:37EDGAR2Form 144 - Report of proposed sale of securities
08.11.202322:06EDGAR2Form 8-K - Current report
08.11.202322:00GLOBEAkoya Reports Record Revenue in the Third Quarter of 2023..
02.11.202313:00GLOBEAkoya to Participate at Three Upcoming Investor Conferences
31.10.202314:00GLOBEAkoya Biosciences to Showcase New Spatial Biology 2.0..
17.10.202316:22GLOBEAkoya Biosciences Announces Peer-Reviewed Publication Using..
11.10.202322:05GLOBEAkoya to Report Third Quarter 2023 Financial Results on..
19.9.202314:00GLOBEAkoya Biosciences Sets a New Standard for Scaling Spatial..
06.9.202322:01EDGAR2Form 8-K - Current report
07.8.202322:10EDGAR2Form 8-K - Current report
07.8.202322:05GLOBEAkoya Reports Record Revenue in the Second Quarter of 2023..
07.8.202314:05GLOBEAkoya Biosciences Announces Milestone of 1,000 Peer-Reviewed..
26.7.202322:05GLOBEAkoya to Participate at Three Upcoming Investor Conferences
13.7.202323:10EDGAR2Form 144 - Report of proposed sale of securities
13.7.202300:28EDGAR2Form 144 - Report of proposed sale of securities
12.7.202314:05GLOBEAkoya to Report Second Quarter 2023 Financial Results on..
05.7.202322:05EDGAR2Form 8-K - Current report
28.6.202323:18EDGAR2Form 8-K - Current report
12.6.202322:05GLOBEAkoya to Participate at Two Upcoming Investor Conferences
08.6.202306:55GLOBEAkoya Biosciences Announces Pricing of Public Offering of..
08.6.202302:08DJNAkoya Biosciences Shares Fall on Executive Exits, Stock..
07.6.202322:08GLOBEAkoya Biosciences Announces Public Offering of Common Stock
08.5.202322:05GLOBEAkoya Reports Record Revenue in the First Quarter of 2023..

Kürzlich von Ihnen besucht

NASDAQ
AKYA
Akoya BioSciences
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten